[Testing the acid-binding capacity of Tisacid suspension and tablets by intragastric pH determination in patients with hyperacidity].
The effect of a Hungarian Al-Mg-containing drug, called Tisacid was studied using of 2.0, 1.0 and 0.5 gram doses. Two administration forms, suspension and tablet were compared. Ten informed, adult hyperacid volunteers were included into the program and three times 5-hour intragastric pH-metry was carried out in a randomized, self-controlled open clinical study (Control, after administration of tablet or suspension). Both forms were found effective in gastric acid reduction at doses of 2.0 and 1.0 g. Tisacid suspension revealed a more pronounced efficacy at the dose of 2.0 g in comparison to the same dose of tablet form. The 0.5 g dose seemed insufficient in reduction of gastric acidity in hyperacid patients applied in tablet or suspension forms. The authors emphasize the role of continuous intragastric pH-metry in clinical practice and investigation of antacids and antisecretory drugs.
Hunyady
B
B
Pécsi Orvostudományi Egyetem, I. Belgyógyászati Klinika.
Ciráki
A
A
Vińcze
A
A
Garamszegi
M
M
Nagy
L
L
Jávor
T
T
D000328:Adult; D000536:Aluminum Hydroxide; D000863:Antacids; D002254:Carbonates; D005260:Female; D005745:Gastric Acidity Determination; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008276:Magnesium Hydroxide; D008297:Male; D008875:Middle Aged; D013535:Suspensions; D013607:Tablets
D000863:Antacids; D002254:Carbonates; D013535:Suspensions; D013607:Tablets; C043698:almagate; D000536:Aluminum Hydroxide; D008276:Magnesium Hydroxide
Tisacid szuszpenzió és tabletta savkötö képességének vizsgálata intragasztrikus pH-méréssel hiperacid betegekben.